Fortive Corporation delivered solid fourth quarter and full year 2025 results, exceeding expectations with Q4 revenue of $1.1 billion (+4.5% YoY) and adjusted EPS of $0.90 (+13% YoY). Full-year adjusted EPS reached $2.71, surpassing the high end of guidance, driven by an 8% increase in adjusted EBITDA to $358 million and robust free cash flow conversion of over 100%. Performance was bolstered by the 'New Fortive' strategy, specifically the Fortive Accelerator pillars, which drove core growth of 3% and margin expansion in the Intelligent Operating Systems (iOS) segment, while Advanced Healthcare Solutions (AHS) showed improving demand trends despite prior headwinds. The company returned significant capital to shareholders, repurchasing $1.3 billion in shares in the second half of the year. Looking ahead, management initiated 2026 guidance for adjusted EPS of $2.90 to $3.00, representing approximately 9% growth at the midpoint, with core revenue growth expected between 2% and 3%.
| Metric | Value | Change |
|---|---|---|
| Q4 Revenue | $1.1 Billion | +4.5% YoY (Reported) |
| Q4 Core Growth | 3% | Just over 3% |
| Q4 Adjusted EBITDA | $358 Million | +8% YoY |
| Q4 Adjusted EBITDA Margin | ~32% | +100 bps YoY |
| Q4 Adjusted EPS | $0.90 | +13% YoY |
| FY 2025 Adjusted EPS | $2.71 | +12% YoY |
| FY 2025 Free Cash Flow | $930 Million | Conversion >100% |
| Share Repurchases (2H 2025) | $1.3 Billion | N/A |
| 2026 EPS Guidance | $2.90 - $3.00 | ~9% at midpoint |
| 2026 Core Revenue Growth Guidance | 2% - 3% | N/A |
Management emphasized the 'Fortive Accelerator' strategy as the primary driver for future value creation, focusing on three pillars: accelerating profitable organic growth, disciplined capital allocation, and building investor trust. The strategy appears to be gaining traction, evidenced by Q4 core growth of over 3% and adjusted EBITDA growth of 8%, which management attributed to the power of the Fortive Business System (FBS). This strategic pivot is central to the investment thesis, as they aim to deliver 'benchmark-beating shareholder returns' through operational rigor and targeted commercial investments.
Innovation and AI integration are being leveraged as key growth differentiators, particularly within the software and instrumentation platforms. Management highlighted the launch of Fluke's 'Certified Max' data center solution and ServiceChannel's AI-enhanced third product release. CEO Olumide Soroye explicitly stated that AI is viewed as an 'opportunity' rather than a threat, driving 'AgenTeq and GenAI-powered enhancements' that deepen workflow integration. This focus on high-value, mission-critical software creates a sticky revenue stream and supports premium valuations.
Capital allocation remains a core strategic pillar, with a clear priority on returning cash to shareholders through aggressive share repurchases. In 2025, the company repurchased approximately 26 million shares (roughly 8% of diluted shares outstanding), including $1.3 billion in the second half alone. Management signaled continued discipline, stating they will prioritize bolt-on M&A only where returns exceed other uses of capital, while maintaining a 'modest growing dividend.' This aggressive buyback program underscores management's confidence in intrinsic value and provides a floor for the stock.
Commercial execution is improving through targeted investments in high-growth verticals and regions. Management cited specific successes in data centers, defense, and India, where expanded sales teams directly contributed to strong growth. The iOS segment outperformed expectations with 4% core growth, driven by 'FBS-driven commercial and operational execution.' This indicates that the 'New Fortive' is successfully translating strategic plans into operational wins, which is critical for sustaining the 9% EPS growth guidance for 2026.
The Advanced Healthcare Solutions (AHS) segment continues to face headwinds from hospital capital expenditure deferrals and reimbursement policy changes. While management noted demand trends improved in Q4, the segment's core growth of 1.6% significantly lags the iOS segment. Management admitted that capital equipment revenue recognition remains pressured by cautious customer spending, creating a risk that the anticipated recovery in AHS could be delayed if macroeconomic conditions tighten further.
Gross margin pressure was evident in Q4, with consolidated adjusted gross margin declining approximately 150 basis points year-over-year to 63%. Management attributed this to product mix, the net effect of tariffs and countermeasures, and targeted growth investments. While they expect to manage this through cost discipline, the combination of tariffs and a shift toward lower-margin recurring revenue streams could compress profitability if not offset by significant operating leverage.
Management adopted a cautious stance regarding the sustainability of the international recovery, specifically in Europe and APAC. While they noted 'green shoots' and 'encouraging improvements,' they explicitly refused to call it a 'sustained trend' or a 'market inflection.' This prudence suggests that the 2-3% core revenue growth guidance for 2026 might rely heavily on execution rather than a macro tailwind, leaving little room for error if commercial teams stumble.
The guidance for 2026 implies a deceleration in top-line growth compared to the Q4 performance in iOS. While iOS grew 4% core in Q4, the company guided for only 2-3% core growth for the full year 2026. Management explained this by stating they are 'not presuming a change in [macro] that's significant either way,' effectively baking in flat market conditions. This conservative outlook raises concerns about the company's ability to grow faster than the market without an economic upswing.
Overall: Management exhibited a high level of confidence and enthusiasm throughout the call, frequently using terms like 'strong conviction,' 'optimism,' and 'unrelenting focus.' The tone shifted from disciplined operational reporting in prepared remarks to a more engaging and forward-looking demeanor during the Q&A, where they emphasized the 'momentum building' behind the new strategic initiatives.
Confidence: HIGH - Management consistently expressed confidence in the 'New Fortive' strategy and its early execution. They provided specific guidance ranges for 2026 with a relatively tight spread ($0.10), citing improved forecasting and a 'good command on the cost structure.' The language was decisive regarding capital allocation and the ability to meet the multi-year financial framework.
$2.90 to $3.00 per share
Nearly $4.3 billion
2% to 3%
Mid-teens (Q1-Q3 high teens, Q4 high single/low double digits)
Just over $120 million
Roughly 315 million shares
Hedging & Uncertainty: Management employed a mix of confident assertions regarding internal execution and prudent hedging around external macro factors. Phrases like 'green shoots,' 'early signs,' and 'not yet a sustained trend' were used to describe improvements in Europe and APAC, indicating they are not relying on a geographic recovery for their targets. However, hedging was minimal regarding their internal capabilities, using strong verbs like 'diligently executing,' 'accelerating,' and 'unrelenting focus.' When discussing AI, they moved from defensive to opportunistic, framing it as a 'strong pull from customers' rather than a competitive threat.
We enter 2026 with optimism, enthusiasm, and an unrelenting focus on execution. - Olumide Soroye, CEO
We are diligently executing the Fortive Accelerator strategy to deliver benchmark-beating shareholder returns. - Olumide Soroye, CEO
We recognize there is more work to do here, and we remain confident and focused on delivering the 2026-2027 financial framework. - Olumide Soroye, CEO
We're off to a strong start at New Fortive... momentum is building, and we're excited about what lies ahead. - Mark D. Okerstrom, CFO
It hasn't escaped our attention that the bar is really high right now if you're looking at any software assets. - Olumide Soroye, CEO
We're trying to be really clear-eyed and prudent before we call a single quarter a new trend. - Olumide Soroye, CEO
Analyst Sentiment: Analysts were generally inquisitive and constructive, focusing heavily on the sustainability of the growth in the Intelligent Operating Systems (iOS) segment and the specific mechanics of the AI strategy. There was skepticism regarding the conservatism of the 2026 guidance relative to Q4 performance, and questions about the 'New Fortive' execution cadence.
Management Responses: Management responses were detailed and confident, often pivoting questions about macro demand back to internal execution capabilities. They provided specific color on product launches (Fluke, ServiceChannel) and regional performance to back up their claims. They were transparent about the localized nature of AHS margin investments and the high bar for software M&A.
Discussion on Fluke's end market demand and sell-through, with management confirming strong POS trends and channel inventory improvements. - Olumide Soroye
Inquiry into price/cost dynamics and tariff impacts, with management noting a 2% price contribution in Q4 and expectations for margin expansion through P&L levers. - Mark D. Okerstrom
Questions regarding the sustainability of AHS margins, clarified as localized Q4 investments rather than a multi-year structural change. - Olumide Soroye
Deep dive into the competitive landscape for software and AI, where management framed AI as an opportunity for 'mission-critical' enterprise software rather than a disruption risk. - Olumide Soroye
Clarification on the tightness of the 2026 EPS guidance range, attributed to business durability, forecasting improvements, and share repurchase tailwinds. - Mark D. Okerstrom
Fortive is successfully executing its 'New Fortive' turnaround strategy, evidenced by a solid beat-and-raise quarter and aggressive capital return. The shift to a focused two-segment structure (iOS and AHS) combined with the Fortive Accelerator strategy is driving operational leverage, with iOS delivering 4% core growth and margin expansion. Management's confidence is high, supported by a 13% EPS beat in Q4 and the initiation of 2026 guidance implying 9% growth. The company is effectively balancing investment in innovation (AI, data centers) with strict financial discipline, repurchasing 8% of its float in 2025. While AHS headwinds and tariff impacts remain near-term risks, the clear path to margin expansion, the durability of recurring revenue, and the commitment to shareholder returns make the risk/reward profile attractive at this stage of the transformation.
Management noted solid demand in short-cycle businesses like Fluke, with North America remaining the strongest region. They observed 'green shoots' in Europe and LatAm but stopped short of calling it a sustained trend.
Hospital capital expenditure deferrals and reimbursement policy changes continue to pressure the AHS segment, though management noted demand trends 'improved again in Q4' and are 'getting better literally by the week.'
FX is expected to be a tailwind of approximately 300 basis points in Q1 2026, though this benefit is expected to ease as the year progresses.
Tariffs and related countermeasures impacted Q4 gross margins by roughly 150 basis points. Management assumes current rates for 2026 guidance and expects the net impact not to be meaningful to the bottom line.